ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Clinical trials for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) explained in plain language.
Never miss a new study
Get alerted when new ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) trials appear
Sign up with your email to follow new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists scan brains to see how ADHD drugs work in autistic kids
Disease control Recruiting nowThis 10-week study is testing how well a common ADHD medication (Adderall XR) works for children and teens who have both autism and ADHD. Researchers will use brain scans and symptom checklists to see if the medication improves attention and reduces hyperactivity, and whether it …
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE4 • Sponsor: Gagan Joshi • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for the 'Double Diagnosis': common ADHD drug tested for depression relief
Disease control Recruiting nowThis study is testing whether a stimulant medication, dexamfetamine, can help adults who have both ADHD and moderate to severe depression. Researchers will compare two different pill formulations (one long-acting, one short-acting) against a placebo (sugar pill) in 105 participan…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE2 • Sponsor: Prof. Dr. Frank Behrens • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New pill tested to help kids focus
Disease control Recruiting nowThis study is testing a new, once-daily capsule called EB-1020 to see if it can help control the core symptoms of ADHD in children and teenagers. It will compare two different doses of the medication against a placebo (a capsule with no active drug) over six weeks. The goal is to…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE2, PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Year-Long test for new ADHD pill in kids
Disease control Recruiting nowThis study aims to check the long-term safety of a daily medication called EB-1020 for children and teenagers with ADHD. It will follow about 180 participants for 52 weeks to see how they tolerate the treatment. The main goal is to monitor for any side effects that may occur duri…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Can a Child's footprint reveal ADHD? new study uses AI to find out
Diagnosis Recruiting nowThis study aims to see if a computer can predict ADHD in children by analyzing their foot pressure patterns and posture. Researchers will collect data from 100 middle school students, including those with ADHD and those without, using non-invasive foot pressure mats and posture a…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Sponsor: Biruni University • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
VR headset could slash teen driving crashes linked to ADHD
Prevention Recruiting nowThis study is testing a new, more affordable virtual reality (VR) version of a driving safety program for teens with ADHD. The goal is to train teens to keep their eyes on the road and avoid dangerous, long glances away while driving. Researchers will compare the new VR training …
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Mar 25, 2026 14:07 UTC
-
Could an ADHD pill help kids with sickle cell disease focus in school?
Symptom relief Recruiting nowThis study is testing if a daily ADHD medication called methylphenidate is practical, safe, and acceptable for children with sickle cell disease who struggle with attention, memory, and thinking. About 30 children, aged 8 to 18, will take the medication once a day for four weeks.…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Brain brew: can tea and coffee compounds sharpen focus for ADHD and autism?
Symptom relief Recruiting nowThis small pilot study is testing whether a combination of two natural compounds found in tea and coffee—L-theanine and paraxanthine—can temporarily improve focus, attention, and thinking in adults with ADHD or autism. Researchers will use brain scans and thinking tests to compar…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: NA • Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
Scientists track Kids' sleep and activity to unlock ADHD mysteries
Knowledge-focused Recruiting nowThis study aims to understand how sleep patterns, daily physical activity, and natural body rhythms are connected to the different ways ADHD symptoms show up in children. Researchers will use wearable wristbands and brain scans to measure these factors in about 200 children, some…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: NA • Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists hunt for genetic clues to predict which ADHD meds work best
Knowledge-focused Recruiting nowThis study aims to find genetic patterns that can predict how well children and teens with ADHD will respond to common stimulant medications like Concerta. Researchers will follow 400 participants aged 6-24 in Western Canada who are starting this type of medication. The goal is t…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Sponsor: University of Calgary • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC